Agile therapeutics announces pricing of $45 million underwritten public offering of common stock

Princeton, n.j., feb. 21, 2020 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx), a women’s healthcare company, today announced the pricing of its underwritten public offering of 15 million shares of its common stock at a public offering price of $3.00 per share. the gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by agile therapeutics, are expected to be approximately $45 million. in addition, agile therapeutics has granted the underwriters a 30-day option to purchase up to 2.25 million additional shares of common stock at the public offering price, less the underwriting discounts and commissions. all shares in the offering will be sold by agile therapeutics.
AGRX Ratings Summary
AGRX Quant Ranking